Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Feifel

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Brain Research|December 10, 1990
Central somatostatin: a re-examination of its effects on feedingD Feifel, F J Vaccarino
Pharmacology, Biochemistry, and Behavior|November 5, 1997
Cysteamine blocks amphetamine-induced deficits in sensorimotor gatingD Feifel, K L Minor
Behavioural Brain Research|December 14, 1999
Effects of neurotensin administered into the ventral tegmental area on prepulse inhibition of startleD Feifel, T L Reza
Synapse (New York, N.Y.)|January 5, 2002
Decreased haloperidol-induced potentiation of zif268 mRNA expression in the nucleus accumbens shell and the dorsal lateral striatum of rats lacking cholecystokinin-A receptorsP D Shilling, D Feifel
The Journal of Clinical Psychiatry|February 1, 1997
Iron overload among a psychiatric outpatient populationD Feifel, C W Young
Psychopharmacology|November 9, 2002
SR146131, a cholecystokinin-A receptor agonist, antagonizes prepulse inhibition deficits produced by dizocilpine and DOIP D Shilling, D Feifel
Neuroscience and Biobehavioral Reviews|January 1, 1994
Growth hormone-regulatory peptides (GHRH and somatostatin) and feeding: a model for the integration of central and peripheral functionD Feifel, F J Vaccarino
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 14, 1999
Antipsychotic potential of CCK-based treatments: an assessment using the prepulse inhibition model of psychosisD Feifel, T Reza, S Robeck
The Journal of Clinical Psychiatry|February 24, 2001
Safety and tolerability of a rapidly escalating dose-loading regimen for risperidoneD Feifel, C Y Moutier, W Perry
Behavioural Brain Research|July 5, 2003
The effects of systemic NT69L, a neurotensin agonist, on baseline and drug-disrupted prepulse inhibitionP D Shilling, E Richelson, D Feifel
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Brain Research|December 10, 1990
Central somatostatin: a re-examination of its effects on feedingD Feifel, F J Vaccarino
Pharmacology, Biochemistry, and Behavior|November 5, 1997
Cysteamine blocks amphetamine-induced deficits in sensorimotor gatingD Feifel, K L Minor
Behavioural Brain Research|December 14, 1999
Effects of neurotensin administered into the ventral tegmental area on prepulse inhibition of startleD Feifel, T L Reza
Synapse (New York, N.Y.)|January 5, 2002
Decreased haloperidol-induced potentiation of zif268 mRNA expression in the nucleus accumbens shell and the dorsal lateral striatum of rats lacking cholecystokinin-A receptorsP D Shilling, D Feifel
The Journal of Clinical Psychiatry|February 1, 1997
Iron overload among a psychiatric outpatient populationD Feifel, C W Young
Psychopharmacology|November 9, 2002
SR146131, a cholecystokinin-A receptor agonist, antagonizes prepulse inhibition deficits produced by dizocilpine and DOIP D Shilling, D Feifel
Neuroscience and Biobehavioral Reviews|January 1, 1994
Growth hormone-regulatory peptides (GHRH and somatostatin) and feeding: a model for the integration of central and peripheral functionD Feifel, F J Vaccarino
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 14, 1999
Antipsychotic potential of CCK-based treatments: an assessment using the prepulse inhibition model of psychosisD Feifel, T Reza, S Robeck
The Journal of Clinical Psychiatry|February 24, 2001
Safety and tolerability of a rapidly escalating dose-loading regimen for risperidoneD Feifel, C Y Moutier, W Perry
Behavioural Brain Research|July 5, 2003
The effects of systemic NT69L, a neurotensin agonist, on baseline and drug-disrupted prepulse inhibitionP D Shilling, E Richelson, D Feifel
Pageof 4